Eupraxia Pharmaceuticals Files 6-K for 2025 Annual Report
Ticker: EPRX · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1581178
Sentiment: neutral
Topics: annual-report, regulatory-filing, pharmaceuticals
TL;DR
Eupraxia Pharma (EPRX) filed its 2025 annual report (40-F) on 7/22.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 22, 2025, indicating it is submitting its annual report under cover of Form 40-F. The company, located in Victoria, British Columbia, Canada, operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing signals that Eupraxia Pharmaceuticals is meeting its reporting obligations for its annual financial performance, which is crucial for investors to assess the company's health and prospects.
Risk Assessment
Risk Level: low — This is a routine administrative filing for an annual report, not indicating any new material events or risks.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Registrant
- 001-41923 (other) — Commission File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (address) — Registrant's principal executive office
- July 2025 (date) — Reporting period
- 20250722 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report that Eupraxia Pharmaceuticals Inc. is submitting its annual report under cover of Form 40-F.
What is the Commission File Number for Eupraxia Pharmaceuticals Inc.?
The Commission File Number for Eupraxia Pharmaceuticals Inc. is 001-41923.
Where is Eupraxia Pharmaceuticals Inc. located?
Eupraxia Pharmaceuticals Inc. is located at 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
For what period is Eupraxia Pharmaceuticals Inc. filing its annual report?
Eupraxia Pharmaceuticals Inc. is filing its annual report for the month of July 2025, under cover of Form 40-F.
What type of company is Eupraxia Pharmaceuticals Inc. classified as?
Eupraxia Pharmaceuticals Inc. is classified under Standard Industrial Classification code 2834, which is Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding EUPRAXIA PHARMACEUTICALS INC. (EPRX).